P905: PATIENT REPORTED OUTCOMES IN TRIPLE CLASS EXPOSED, RELAPSED/REFRACTORY MULTIPLE MYELOMA (TCE RRMM) PATIENTS IN KARMMA 3 TRIAL (PHASE 3 RCT): IDECABTAGENE VICLEUCEL (IDE-CEL) VERSUS STANDARD REGIMENS

Autor:	Michel Delforge, Krina Patel, Laurie Eliason, Devender Dhanda, Ling Shi, Shien Guo, Thomas Marshall, Bertrand Arnulf, Michele Cavo, Ajay Nooka, Salomon Manier, Natalie Callander, Sergio Giralt, Hermann Einsele, Sikander Ailawadhi, Mihaela Popa Mckiver, Mark Cook, Paula Rodríguez-Otero
Jazyk:	angličtina
Rok vydání:	2023
Předmět:	Diseases of the blood and blood-forming organs RC633-647.5
Zdroj:	HemaSphere, Vol 7, p e031009e (2023)
Druh dokumentu:	article
ISSN:	2572-9241
DOI:	10.1097/01.HS9.0000970524.03100.9e
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/7af1b5df2c1c479e9aee87fd33b147f2 Zobrazit plný text záznamu Plný text View record in DOAJ